We are a biotechnology company dedicated to developing next-generation therapeutics to improve the lives of patients with severe and life-altering brain diseases. Bright Minds’ broad portfolio of new chemical entities (NCEs) are positioned to treat a variety of pain indications, seizures, and neuropsychiatric disorders.
/image%2F6304363%2F20210203%2Fob_c172f2_brightmindbioscienceca.jpg)
Do you feel weighed down due to prolonged use of medicine for chronic pain or a neurological disease? Millions of people worldwide are prescribed opioid medicines, which have many side effects, including addiction. At Bright Minds Biosciences, we present...
/image%2F6304363%2F20210127%2Fob_59ddb0_drugdevelopercompanybrightminds.jpg)
Epilepsy affects more than 60 million people worldwide. Bright Minds Biosciences, has a unique pipeline of 5-HT2C agonists being evaluated for the treatment of epilepsy, and testing is underway in collaboration with the National Institutes of Health to...
